226 related articles for article (PubMed ID: 8616871)
21. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
[TBL] [Abstract][Full Text] [Related]
22. Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine.
Kayaga J; Souberbielle BE; Sheikh N; Morrow WJ; Scott-Taylor T; Vile R; Chong H; Dalgleish AG
Gene Ther; 1999 Aug; 6(8):1475-81. PubMed ID: 10467372
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of murine melanoma growth by granulocyte-macrophage colony stimulating factor gene transfection is not haplotype specific.
Botella R; Sarradet MD; Potter LE; Lawley M; Galloway TH; Ansel JC; Armstrong CA
Melanoma Res; 1998 Jun; 8(3):245-54. PubMed ID: 9664146
[TBL] [Abstract][Full Text] [Related]
24. Activities of granulocyte-macrophage colony-stimulating factor revealed by gene transfer and gene knockout studies.
Dranoff G; Mulligan RC
Stem Cells; 1994; 12 Suppl 1():173-82; discussion 182-4. PubMed ID: 7696961
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor.
Arca MJ; Krauss JC; Aruga A; Cameron MJ; Shu S; Chang AE
Cancer Gene Ther; 1996; 3(1):39-47. PubMed ID: 8785710
[TBL] [Abstract][Full Text] [Related]
26. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
[TBL] [Abstract][Full Text] [Related]
27. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.
Bowne WB; Wolchok JD; Hawkins WG; Srinivasan R; Gregor P; Blachere NE; Moroi Y; Engelhorn ME; Houghton AN; Lewis JJ
Cytokines Cell Mol Ther; 1999 Dec; 5(4):217-25. PubMed ID: 10850386
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
[TBL] [Abstract][Full Text] [Related]
29. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ
Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells.
Qin Z; Noffz G; Mohaupt M; Blankenstein T
J Immunol; 1997 Jul; 159(2):770-6. PubMed ID: 9218594
[TBL] [Abstract][Full Text] [Related]
31. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells.
Obermueller E; Vosseler S; Fusenig NE; Mueller MM
Cancer Res; 2004 Nov; 64(21):7801-12. PubMed ID: 15520186
[TBL] [Abstract][Full Text] [Related]
32. Up- and down-regulation of granulocyte/macrophage-colony stimulating factor activity in murine skin increase susceptibility to skin carcinogenesis by independent mechanisms.
Mann A; Breuhahn K; Schirmacher P; Wilhelmi A; Beyer C; Rosenau A; Ozbek S; Rose-John S; Blessing M
Cancer Res; 2001 Mar; 61(5):2311-9. PubMed ID: 11280804
[TBL] [Abstract][Full Text] [Related]
33. A new mouse model of experimental melanoma for vaccine and lymphokine therapy.
Shrayer DP; Bogaars H; Wolf SF; Hearing VJ; Wanebo HJ
Int J Oncol; 1998 Aug; 13(2):361-74. PubMed ID: 9664134
[TBL] [Abstract][Full Text] [Related]
34. Genetically engineered tumor cell vaccine in a head and neck cancer model.
Couch M; Saunders JK; O'Malley BW; Pardoll D; Jaffee E
Laryngoscope; 2003 Mar; 113(3):552-6. PubMed ID: 12616213
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice.
Cao X; Ju DW; Tao Q; Wang J; Wan T; Wang BM; Zhang W; Hamada H
Gene Ther; 1998 Aug; 5(8):1130-6. PubMed ID: 10326037
[TBL] [Abstract][Full Text] [Related]
36. Preclinical development of human granulocyte-macrophage colony-stimulating factor-transfected melanoma cell vaccine using established canine cell lines and normal dogs.
Hogge GS; Burkholder JK; Culp J; Albertini MR; Dubielzig RR; Yang NS; MacEwen EG
Cancer Gene Ther; 1999; 6(1):26-36. PubMed ID: 10078961
[TBL] [Abstract][Full Text] [Related]
37. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
[TBL] [Abstract][Full Text] [Related]
38. [Effect of Fluorouracil-inducible GM-CSF gene therapy regulated by Egr-1 promoter on chemotherapeutic hematopoietic damage of tumor-bearing mice].
Du N; Pei XT; Xiao WH; Sun JZ; Fu Y; Zhao H; Wang XL
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1281-6. PubMed ID: 19595187
[TBL] [Abstract][Full Text] [Related]
39. Antigens and cytokine genes in antitumor vaccines: the importance of the temporal delivery sequence in antitumor signals.
Herrero MJ; Botella R; Dasí F; Algás R; Sánchez M; Aliño SF
Ann N Y Acad Sci; 2006 Dec; 1091():412-24. PubMed ID: 17341632
[TBL] [Abstract][Full Text] [Related]
40. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
Cao X; Huang X; Ju DW; Zhang W; Hamada H; Wang J
Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
